Paul Ehrlich and Ludwig Darmstaedter award, which is accepted as one of the important awards of the medical world in GERMANY, developed the new type of coronavirus (Kovid-19) vaccine. Dr. Ugur Sahin, Dr. Özlem Türeci and Prof. Dr. Katalin was given to Kariko.
In the statement made by the Paul Ehrlich Foundation, “Prof. Dr. Uğur Şahin, Dr. Özlem Türeci and Prof. Dr. Katalin Kariko were awarded the Paul Ehrlich and Ludwig Darmstaedter award for their vision and perseverance in the development of mRNA as a principle in preventing and treating disease. seen”.
“The three award winners are honored for their achievements in the development of mRNA for preventive and therapeutic purposes. They have created a technology platform that is likely to revolutionize some fields of medicine,” the statement said.
Şahin and Türeci, the founding partners of the German biotechnology company BioNTech, which developed the new type of coronavirus (Kovid-19) vaccine, and Hungarian origin Katalin Kariko, the vice president of the company, will receive the award worth 120 thousand euros at a ceremony to be held in Frankfurt on March 14, 2022.